Vimarsana
Biggest News Aggregation in the World

Page 6 - Nasdaq Coll News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Coll. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Coll Today - Breaking & Trending Today

Needham & Company LLC Reaffirms Buy Rating for Collegium Pharmaceutical (NASDAQ:COLL) - Vimarsana News

Needham & Company LLC Reaffirms Buy Rating for Collegium Pharmaceutical (NASDAQ:COLL)

Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at Needham & Company LLC in a research report issued on Friday, Benzinga reports. They presently have a $35.00 price objective on the specialty pharmaceutical company’s stock. Needham & Company LLC’s price objective would suggest a potential upside of […]

Source: wkrb13.com
Emerald Mutual Fund Advisers Trust Trims Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Vimarsana News

Emerald Mutual Fund Advisers Trust Trims Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

Emerald Mutual Fund Advisers Trust decreased its holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 1.3% in the 1st quarter, Holdings Channel reports. The firm owned 677,160 shares of the specialty pharmaceutical company’s stock after selling 8,733 shares during the period. Emerald Mutual Fund Advisers Trust’s holdings in Collegium Pharmaceutical were worth $16,245,000 […]

Foundry Partners LLC Invests $3.27 Million in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Vimarsana News

Foundry Partners LLC Invests $3.27 Million in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

Foundry Partners LLC acquired a new position in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 136,480 shares of the specialty pharmaceutical company’s stock, valued at approximately $3,274,000. Foundry […]

Collegium Pharmaceutical (NASDAQ:COLL) Downgraded by StockNews.com - Vimarsana News

Collegium Pharmaceutical (NASDAQ:COLL) Downgraded by StockNews.com

StockNews.com lowered shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) from a buy rating to a hold rating in a research report report published on Monday morning. Several other analysts also recently weighed in on the company. Needham & Company LLC restated a buy rating and set a $35.00 target price on shares of Collegium […]

Source: wkrb13.com
Insider Selling: Collegium Pharmaceutical, Inc. (NASDAQ:COLL) EVP Sells 17,984 Shares of Stock - Vimarsana News

Insider Selling: Collegium Pharmaceutical, Inc. (NASDAQ:COLL) EVP Sells 17,984 Shares of Stock

Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) EVP Shirley R. Kuhlmann sold 17,984 shares of Collegium Pharmaceutical stock in a transaction dated Monday, June 26th. The shares were sold at an average price of $21.72, for a total transaction of $390,612.48. Following the transaction, the executive vice president now directly owns 119,518 shares of the […]